SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-20-000542
Filing Date
2020-02-14
Accepted
2020-02-14 15:17:34
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO 2 TO THE SCHEDULE 13G sc13ga207422mac_02142020.htm SC 13G/A 266787
2 JOINT FILING AGREEMENT ex991to13ga207422mac_021420.htm EX-99.1 10398
  Complete submission text file 0000921895-20-000542.txt   278773
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Subject) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86778 | Film No.: 20618608
SIC: 2834 Pharmaceutical Preparations